Molecular Partners Ag Stock Technical Analysis
| MOLN Stock | USD 5.83 0.18 3.19% |
As of the 28th of November, Molecular Partners secures the Standard Deviation of 7.21, mean deviation of 4.53, and Risk Adjusted Performance of 0.0063. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Molecular Partners, as well as the relationship between them.
Molecular Partners Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Molecular, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MolecularMolecular |
Molecular Partners Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 10.28 | Strong Buy | 3 | Odds |
Most Molecular analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Molecular stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Molecular Partners, talking to its executives and customers, or listening to Molecular conference calls.
Molecular Partners technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Molecular Partners Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Molecular Partners volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Molecular Partners Trend Analysis
Use this graph to draw trend lines for Molecular Partners AG. You can use it to identify possible trend reversals for Molecular Partners as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Molecular Partners price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Molecular Partners Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Molecular Partners AG applied against its price change over selected period. The best fit line has a slop of 0.01 , which means Molecular Partners AG will continue generating value for investors. It has 122 observation points and a regression sum of squares at 7.4, which is the sum of squared deviations for the predicted Molecular Partners price change compared to its average price change.About Molecular Partners Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Molecular Partners AG on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Molecular Partners AG based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Molecular Partners price pattern first instead of the macroeconomic environment surrounding Molecular Partners. By analyzing Molecular Partners's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Molecular Partners's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Molecular Partners specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 1.0K | 3.27 | 90.5 | 85.97 | PTB Ratio | 5.15 | 0.85 | 0.64 | 0.61 |
Molecular Partners November 28, 2024 Technical Indicators
Most technical analysis of Molecular help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Molecular from various momentum indicators to cycle indicators. When you analyze Molecular charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0063 | |||
| Market Risk Adjusted Performance | (0.01) | |||
| Mean Deviation | 4.53 | |||
| Coefficient Of Variation | (28,528) | |||
| Standard Deviation | 7.21 | |||
| Variance | 52.02 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (1.12) | |||
| Treynor Ratio | (0.02) | |||
| Maximum Drawdown | 52.92 | |||
| Value At Risk | (8.53) | |||
| Potential Upside | 9.38 | |||
| Skewness | 2.46 | |||
| Kurtosis | 12.77 |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Molecular Partners AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Molecular Partners. If investors know Molecular will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Molecular Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.13) | Revenue Per Share 0.182 | Quarterly Revenue Growth (0.73) | Return On Assets (0.21) | Return On Equity (0.37) |
The market value of Molecular Partners is measured differently than its book value, which is the value of Molecular that is recorded on the company's balance sheet. Investors also form their own opinion of Molecular Partners' value that differs from its market value or its book value, called intrinsic value, which is Molecular Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Molecular Partners' market value can be influenced by many factors that don't directly affect Molecular Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Molecular Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if Molecular Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Molecular Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.